Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Projecting future drug expenditures--1997

B Mehl1, J P Santell

  • 1Department of Pharmacy, Mount Sinai Medical Center, New York, NY, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|January 15, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2002
Same author

Harvey A. K. Whitney Lecture. Pharmacy and the complexity of health care.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same author

Projecting future drug expenditures--2001.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same author

ASHP national survey of pharmacy practice in acute care settings: monitoring, patient education, and wellness--2000.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
Same author

ASHP national survey of pharmacy practice in acute care settings: dispensing and administration--1999.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
Same author

Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation.

American journal of medical genetics·2000
Same journal

Addressing feedback overload in pharmacy residents.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Development of a psychiatric pharmacy internship program at a children's hospital.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Integration of smart infusion pumps with electronic medical records improves safety and staff productivity at a large academic healthcare system.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Correction to: Enhancing opioid overdose education and naloxone distribution through pharmacist-led community outreach.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Safety guidance remains sparse for CGTs.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Cefazolin for all or just some? A review of cefazolin for surgical site infection prophylaxis in patients with β-lactam allergies.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
See all related articles

Projecting 1997 drug expenditures requires analyzing producer price index data, industry analyst forecasts, and group purchasing organizations (GPOs) predictions. Pharmacy budgets must also consider pharmacoeconomics and evolving healthcare landscapes.

Area of Science:

  • Health Economics
  • Pharmaceutical Policy

Background:

  • Forecasting drug expenditures and pharmacy budgets for 1997 involves multiple data sources.
  • Recent price trends and industry projections are crucial for accurate financial planning.

Purpose of the Study:

  • To discuss methods for projecting 1997 drug expenditures and preparing pharmacy budgets.
  • To analyze various data sources and factors influencing drug costs.

Main Methods:

  • Utilized producer price index (PPI) data for drugs and pharmaceuticals.
  • Incorporated data from independent sources, drug industry analysts, group purchasing organizations (GPOs), and health maintenance organizations (HMOs).
  • Considered pharmacoeconomics and legal developments impacting drug pricing.

Related Experiment Videos

Main Results:

  • Producer Price Index showed a 2.2% increase for drugs (3.4% for prescriptions) from Jan-May 1996.
  • Medi-Span reported a 1.2% average drug price increase in H1 1996; IMS America data showed 1.8% increase between Q2 1995-1996.
  • Analysts projected 2.5-5.0% price increases; GPOs predicted 2.2% (contracted) and 4.3% (non-contracted) increases.
  • HMOs projected a 4.5% increase in pharmacy expenditures per member for 1997.

Conclusions:

  • Pharmacoeconomic analysis requires careful application when projecting drug costs.
  • Pharmacy budgets must integrate drug expenditures with institutional objectives, considering factors like capitation, competition, and service relocation.
  • Legal actions may influence future price increases, necessitating adaptation to the changing healthcare landscape.